Plasma pharmacokinetics of ranitidine HCl were investigated after intr
avenous (i.v.) and oral (p.o.) administration of drug to six healthy f
oals. Twelve-to sixteen-week-old foals received 2.2 mg ranitidine/kg i
.v. and 4.4 mg ranitidine/kg p.o. Concentrations of ranitidine were de
termined using normal phase high performance liquid chromatography, Pl
asma concentrations of ranitidine HCl declined from a mean of 3266 ng/
mL at 5 min to 11 ng/mL at 720 min after administration. The profile o
f the plot of concentrations of ranitidine HCl vs, time was best descr
ibed by a two-exponent equation for two foals; data for the remaining
four foals were best described by a three-exponent equation. Mean valu
es for model-independent values were: apparent volume of distribution
(Vd(ss)) = 1.46 L/kg; area under the curve (AUC) = 16 7442 ng.min/mL;
area under the moment curve (AUMC) = 18 068 221 ng.min(2)/mL; mean res
idence time (MRT)= 108.9 min; and clearance (Cl)= 13.3 mL/min.kg. Foll
owing p.o. administration, a two-exponent equation best described data
for five foals; data for the remaining foal were best described by a
three-exponent equation. Mean values of the pharmacokinetic values fro
m the p.o. study include: AUC = 12 6413 ng.min/mL; AUMC = 18 039 825 n
g.min(2)/mL; mean absorption time (MAT)= 32.0 min; observed time to ma
ximum plasma concentration (T-max)= 57.2 min; maximum observed plasma
concentration (C-max)= 635.7 ng/mL; and bioavailability (F) = 38%.